Nicholas Bernthal, MD

University of California Los Angeles
Los Angeles, California, United States

Disclosure information not submitted.

Presentation(s):

• Paper 27 - SAFETY AND EFFICACY UPDATES FROM A PHASE 1 STUDY OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR

  Thursday, November 2, 2023
  4:00 PM – 5:30 PM